BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 12271720)

  • 1. [The investigation of the safety, genetic stability and immunogenicity of live influenza vaccine for adults in vaccination of 3-6 years old children].
    Desheva IuA; Danini GV; Grigor'eva EP; Donina SA; Kiseleva IV; Rekstin AR; Ermakova LA; Natsina VK; Nikolaeva VM; Lonskaia NI; El'shina GA; Zhavoronkov VG; Drinevskiĭ VP; Erofeeva MK; Naĭkhin AN; Rudenko LG
    Vopr Virusol; 2002; 47(4):21-4. PubMed ID: 12271720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The comparative characteristics of the safety, immunogenic activity and prophylactic potency of the adult and children types of live influenza vaccine in schoolchildren aged 7-14 years].
    Grigor'eva EP; Desheva IuA; Donina SA; Naĭkhin AN; Rekstin AR; Barantseva IB; Zavitkova EA; Moskvicheva TM; Zhavoronkov VG; Rudenko LG
    Vopr Virusol; 2002; 47(4):24-7. PubMed ID: 12271721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Advantages and disadvantages of inactivated and live influenza vaccine].
    Gendon IuZ
    Vopr Virusol; 2004; 49(4):4-12. PubMed ID: 15293504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in young infants.
    Karron RA; Belshe RB; Wright PF; Thumar B; Burns B; Newman F; Cannon JC; Thompson J; Tsai T; Paschalis M; Wu SL; Mitcho Y; Hackell J; Murphy BR; Tatem JM
    Pediatr Infect Dis J; 2003 May; 22(5):394-405. PubMed ID: 12792378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine-naive children.
    Bracco Neto H; Farhat CK; Tregnaghi MW; Madhi SA; Razmpour A; Palladino G; Small MG; Gruber WC; Forrest BD;
    Pediatr Infect Dis J; 2009 May; 28(5):365-71. PubMed ID: 19395948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A comparative study of live and inactivated influenza vaccines: the organization of the observation and the results of a study of their reactogenicity and immunogenicity].
    Slepushkin AN; Rudenko LG; Kendal AP; Monto AS; Beliaev AL; Burtseva EI; Grigor'eva EP; Obrosova-Serova NP; Ivanova VT; Bragina VE
    Vopr Virusol; 1994; 39(3):129-31. PubMed ID: 8091754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated immunization of children with inactivated and live attenuated influenza virus vaccines: safety, immunogenicity, and protective efficacy.
    Keitel WA
    Semin Pediatr Infect Dis; 2002 Apr; 13(2):112-9. PubMed ID: 12122949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children.
    Piedra PA; Gaglani MJ; Kozinetz CA; Herschler GB; Fewlass C; Harvey D; Zimmerman N; Glezen WP
    Pediatrics; 2007 Sep; 120(3):e553-64. PubMed ID: 17698577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-reactive H1N1 antibody responses to a live attenuated influenza vaccine in children: implication for selection of vaccine strains.
    Lee MS; Yang CF
    J Infect Dis; 2003 Nov; 188(9):1362-6. PubMed ID: 14593595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children.
    Belshe RB; Mendelman PM; Treanor J; King J; Gruber WC; Piedra P; Bernstein DI; Hayden FG; Kotloff K; Zangwill K; Iacuzio D; Wolff M
    N Engl J Med; 1998 May; 338(20):1405-12. PubMed ID: 9580647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal live attenuated seasonal influenza vaccine: does not challenge current practice.
    Prescrire Int; 2013 Sep; 22(141):201-4. PubMed ID: 24171209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Live cold-adapted influenza vaccine: state-of-the-art].
    Gendon IuZ
    Vopr Virusol; 2011; 56(1):4-17. PubMed ID: 21427948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Assessment of the prophylactic effectiveness of an inactivated influenza vaccine by immunizing schoolchildren in the springtime].
    Vasil'eva RI; Liamtseva GA; Riazantseva TG; Oleĭnikova EV; Sosunov AV
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Mar; (3):10-4. PubMed ID: 2939666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and immunogenicity of a three dose regimen of two tetravalent live-attenuated dengue vaccines in five- to twelve-year-old Thai children.
    Sabchareon A; Lang J; Chanthavanich P; Yoksan S; Forrat R; Attanath P; Sirivichayakul C; Pengsaa K; Pojjaroen-Anant C; Chambonneau L; Saluzzo JF; Bhamarapravati N
    Pediatr Infect Dis J; 2004 Feb; 23(2):99-109. PubMed ID: 14872173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety, immunogenicity and shedding of LAIV4 in HIV-infected and uninfected children.
    Curtis D; Ning MF; Armon C; Li S; Weinberg A
    Vaccine; 2015 Sep; 33(38):4790-7. PubMed ID: 26241950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Live attenuated influenza virus vaccine trial in children.
    Hall CB; Douglas G; Fralonardo SA
    Pediatrics; 1975 Dec; 56(6):991-8. PubMed ID: 1196767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Safety and high immunogenicity for children 3 to 15 of a mono- and a divaccine from recombinant influenza A/Brazil /11/78 (H1N1) and A/Bangkok/1/79 (H3N2) viruses obtained from a special donor attenuation base--the cold-adapted virus A/Leningrad/134/47/57 (H2N2)].
    Polezhaev FI; Budilovskiĭ GN; Garmashova LM; Romeĭko-Gurko IuR; Egorov AIu
    Vopr Virusol; 1983; 28(6):710-4. PubMed ID: 6670253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
    Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P
    J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seasonal influenza vaccines.
    Fiore AE; Bridges CB; Cox NJ
    Curr Top Microbiol Immunol; 2009; 333():43-82. PubMed ID: 19768400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Results of a study of a live intranasal influenza vaccine in the immunization of children 3 to 15 years old].
    Rudenko LG; Grigor'eva EP; Drinevskiĭ VP; Koval' TA; Doroshenko EM
    Zh Mikrobiol Epidemiol Immunobiol; 1988 May; (5):41-6. PubMed ID: 2970743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.